S
Sergio Arpino
Researcher at University of Naples Federico II
Publications - 6
Citations - 25
Sergio Arpino is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 2, co-authored 2 publications receiving 11 citations.
Papers
More filters
Journal ArticleDOI
Urinary Biomarkers: Diagnostic Tools for Monitoring Athletes' Health Status.
Raffaela Pero,Mariarita Brancaccio,Cristina Mennitti,Luca Gentile,Sergio Arpino,Renato de Falco,Eleonora Leggiero,Annaluisa Ranieri,Chiara Pagliuca,Roberta Colicchio,Paola Salvatore,Giovanni D'Alicandro,Giulia Frisso,Barbara Lombardo,Cristina Mazzaccara,Raffaella Faraonio,Olga Scudiero +16 more
TL;DR: This study lays the foundations for the use of a urine test in a team of twelve male basketball players as a means of monitoring numerous biochemical parameters to prevent and/or treat the onset of pathologies, prescribe personalized treatments for each athlete, and monitor the athletes’ health status.
Journal ArticleDOI
Increased Prevalence of Nephrolithiasis and Hyperoxaluria in Paget Disease of Bone
Domenico Rendina,Gianpaolo De Filippo,Daniela Merlotti,Marco Di Stefano,Christian Mingiano,Alfonso Giaquinto,M. Evangelista,Mario Bo,Sergio Arpino,Raffaella Faraonio,Pasquale Strazzullo,Luigi Gennari +11 more
TL;DR: The NL occurrence should be evaluated in PDB patients, particularly in those with polyostotic disease and/or after aminobisphosphonate treatment, in order to apply an adequate prevention strategy.
Journal ArticleDOI
Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)
Maria Antonietta Isgrò,Giusy Trillò,Luigi Russo,Anna Lucia Tornesello,Luigi Buonaguro,Maria Lina Tornesello,Leonardo Miscio,Nicola Normanno,Attilio Antonio Montano Bianchi,Franco M. Buonaguro,Ernesta Cavalcanti,Domenica Rea,Lucia Di Capua,Francesco Labonia,Serena Meola,Annamaria Piscopo,Sergio Arpino,Carmine Di Napoli,Gerardo Esposito,V. Pane,Valentina Delle Donne,Noemi Starita,Andrea Cerasuolo,Mariella Tagliamonte,Egidio Celentano,Anna Crispo,Concetta Montagnese,Giuseppe Porciello,Emanuela Rotondo,R. Simioli,Maria Grazia Grimaldi,Flavia Nocerino,Paola Murino,Stefania D'Auria,Rocco Saviano +34 more
TL;DR: In this article , the antibody response levels and their decline were monitored in an interval of 6-9 months after vaccine administration in the two different cohorts of workers of the INT-IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy): the group of individuals previously infected with SARS-CoV-2 and vaccinated with a single dose; and that of individuals negative for previous exposure to SARS, vaccinated with two doses 21 days apart.
Journal ArticleDOI
Life style and interaction with microbiota in prostate cancer patients undergoing radiotherapy: study protocol for a randomized controlled trial
Patrizia Gnagnarella,Giulia Marvaso,Barbara Alicja Jereczek-Fossa,Ottavio De Cobelli,Maria Claudia Simoncini,Luiz Felipe Nevola Teixeira,Annarita Sabbatini,Gabriella Pravettoni,Harriet Johansson,Luigi Nezi,Paolo Muto,Valentina Borzillo,Egidio Celentano,Anna Crispo,Monica Pinto,Ernesta Cavalcanti,Sara Gandini,Costanza Gavioli,Silvia Ciceri,Maria Carmela Latella,Giulia Corrao,Dario Zerini,Debora Macis,Valentina Aristarco,Gabriele Cozzi,Ketti Mazzocco,Fodor Cristiana Iuliana,Serena Galié,Carlotta Catozzi,Rossella Di Franco,Nunzio De Martino,Maria Grazia Grimaldi,Concetta Montagnese,Melania Prete,Flavia Nocerino,Emanuela Rotondo,Sergio Arpino,Serena Meola,Francesco Labonia,Federica Bellerba +39 more
TL;DR: The Microstyle study as discussed by the authors is a multicentre randomized two-arm crossover clinical trial with 300 men undergoing prostate cancer in two intervention arms: Intervention Group (IG) and Control Group (CG) allocated to the IG will meet a dietitian and a physiotherapist before RT to receive personalized diet and exercise recommendations, according to their health status, to improve overall lifestyle and reduce side effects.
Journal ArticleDOI
Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)
Maria Antonietta Isgrò,Giusy Trillò,Luigi Russo,Anna Lucia Tornesello,Luigi Buonaguro,Maria Lina Tornesello,Leonardo Miscio,Nicola Normanno,Attilio Antonio Montano Bianchi,Franco M. Buonaguro,Ernesta Cavalcanti,Domenica Rea,Lucia Di Capua,Francesco Labonia,Serena Meola,Annamaria Piscopo,Sergio Arpino,Carmine Di Napoli,Gerardo Esposito,V. Pane,Valentina Delle Donne,Noemi Starita,Andrea Cerasuolo,Mariella Tagliamonte,Egidio Celentano,Anna Crispo,Concetta Montagnese,Giuseppe Porciello,Emanuela Rotondo,R. Simioli,Maria Grazia Grimaldi,Flavia Nocerino,Paola Murino,Stefania D'Auria,Rocco Saviano +34 more
TL;DR: In this article , the antibody response levels and their decline were monitored in an interval of 6-9 months after vaccine administration in the two different cohorts of workers of the INT-IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy): the group of individuals previously infected with SARS-CoV-2 and vaccinated with a single dose; and that of individuals negative for previous exposure to SARS, vaccinated with two doses 21 days apart.